respiratory disease diagnostic app
The news follows after the company’s ResAppDx-EU version 2 smartphone app was approved by the Australian TGA as a Class IIa medical device.
        
        
          With these data, CEO Tony Keating said the company will be pursuing European and Australian regulatory submissions.